View Entire Collection
By Clinical Topic
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
TUESDAY, July 3 (HealthDay News) -- The first over-the-counter test to detect antibodies to the virus that causes AIDS has been approved by the U.S. Food and Drug Administration, the agency said Tuesday.
The OraQuick In-Home HIV Test allows anonymous users to swab the upper and lower gums and obtain results within 40 minutes, the FDA said in a news release.
A positive result does not mean the test user is necessarily infected with HIV, but that additional testing should be done by a medical professional, the agency said. Similarly, a negative result does not guarantee that the test user is not infected with HIV, particularly if possible exposure to the virus has come within the prior three months, the FDA warned.
Some 1.2 million people in the United States are infected with HIV, and about one in five is not aware that they're infected, the FDA said, citing estimates from the U.S. Centers for Disease Control and Prevention. About 50,000 people are newly infected each year, the FDA added.
The test is produced by OraSure Technologies, based in Bethlehem, Penn. A clinical version of the test for use in professional settings was approved in 2004.
To learn more about HIV/AIDS, visit AIDS.gov.
Find in-depth content on major issues provided by leading companies in partnership with NursingCenter.com
BD Safety Beyond Needlestick Prevention Learning Center
Sponsored by BD Medical
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top